Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-20 · accession 0001601485-21-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-21 | 2021-09-20 | ELTX | Neylan John F. | See Remarks | S - Sale | $10.07 | -376 | 36.2K | -1% | -$3,786 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-20 | S | D | 376 | $10.07 | 36,241 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.09 inclusive. |